| Bioactivity | SARS-CoV-2 3CLpro-IN-30 (compound 29) is a potent inhibitor of SARS-CoV-2 3CL protease (SARS-CoV-2 3CLpro), with the IC50 and EC50 of 0.04 and 0.3 μM[1]. |
| Formula | C37H37Cl2FN6O3 |
| Molar Mass | 703.63 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hengrui Liu, et al. Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening. Nat Commun. 2025 Jan 2;16(1):152. |
SARS-CoV-2 3CLpro-IN-30
CAS: F: C37H37Cl2FN6O3 W: 703.63
SARS-CoV-2 3CLpro-IN-30 (compound 29) is a potent inhibitor of SARS-CoV-2 3CL protease (SARS-CoV-2 3CLpro), with the IC5
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.